Connection
David Schwartz to Certolizumab Pegol
This is a "connection" page, showing publications David Schwartz has written about Certolizumab Pegol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.144 |
|
|
|
-
Afzali A, Ciorba MA, Schwartz DA, Sharaf M, Fourment C, Ritter T, Wolf DC, Shafran I, Randall CW, Kane SV. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflamm Bowel Dis. 2017 12 19; 24(1):2-4.
Score: 0.144